4//SEC Filing
DeLong Mark Jeffrey 4
Accession 0001127602-23-026187
CIK 0001492422other
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 4:18 PM ET
Size
4.5 KB
Accession
0001127602-23-026187
Insider Transaction Report
Form 4
DeLong Mark Jeffrey
Chief Business & Strat Officer
Transactions
- Sale
Common Stock
2023-10-23$46.04/sh−131$6,031→ 51,622 total
Footnotes (2)
- [F1]This represents shares sold to cover tax withholding on a Restricted Stock Unit release.
- [F2]This includes 412 shares from 04/30/2023 ESPP purchase.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001856078
Filing Metadata
- Form type
- 4
- Filed
- Oct 23, 8:00 PM ET
- Accepted
- Oct 24, 4:18 PM ET
- Size
- 4.5 KB